Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort

The value of gadoxetic acid in the diagnosis of hepatocellular carcinoma (HCC), based on perfusion criteria, is under dispute. This post-hoc analysis of the prospective, phase II, randomized, controlled SORAMIC study compared the accuracy of gadoxetic acid-enhanced dynamic magnetic resonance imaging...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidensticker, Max, Steffen, Ingo G., Bargellini, Irene, Berg, Thomas, Benito, Alberto, Gebauer, Bernhard, Iezzi, Roberto, Loewe, Christian, Karçaaltincaba, Musturay, Pech, Maciej, Sengel, Christian, van Delden, Otto, Vandecaveye, Vincent, Zech, Christoph J., Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870455/
https://www.ncbi.nlm.nih.gov/pubmed/35200551
http://dx.doi.org/10.3390/curroncol29020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870455/
https://www.ncbi.nlm.nih.gov/pubmed/35200551
http://dx.doi.org/10.3390/curroncol29020051

Ejemplares similares